comparemela.com

Latest Breaking News On - Accelerate phenotest - Page 1 : comparemela.com

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results

TUCSON, Ariz., May 2, 2024 /PRNewswire/ Accelerate Diagnostics, Inc. announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review.

Prnewswire accelerate diagnostics incDiagnostics incElite entry numberAccelerate diagnosticsAccelerate phenoAccelerate phenotest

Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA -April 09, 2024 at 06:09 pm EDT

Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA Apr 09, 2024 Enabling rapid, automated microbial identification.

Jack phillipsDiagnostics incAccelerate diagnostics announcesAccelerate arcAccelerate diagnosticsAccelerate phenoAccelerate phenotestAll rights

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRiverside plazaJackw schulerProspectus departmentWilliam blair companyExchange commissionJackw schuler livingCraig hallum capital groupPrnewswire accelerate diagnostics incDiagnostics incLiving trustWilliam blairAccelerate diagnosticsAccelerate phenoAccelerate phenotestAnnual report

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Prnewswire accelerate diagnostics incDiagnostics incDiagnostics scheduled callElite entry numberAccelerate diagnosticsAccelerate phenoAccelerate phenotest

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

/PRNewswire/ Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023..

United statesJack phillipsExchange commission onExchange commissionDiagnostics incWave programAccelerate diagnosticsRestructuring transactionsConference call todayElite entry numberMonths ended juneAccelerate phenoAccelerate phenotestLooking statementsAnnual reportConvertible senior notes

vimarsana © 2020. All Rights Reserved.